Price target
41.980.00 0.00%
The 5 analysts offering 1 year price forecasts for 673 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to 673 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
673 EPS for the last quarter is −0.69 EUR despite the estimation of −0.61 EUR. In the next quarter EPS is expected to reach −0.59 EUR. Track more of CEREVEL THERAP.HLDGS financials and stay on top of what is up with the company.
According to analysts, 673 price target is 41.98 EUR with a max estimate of 41.98 EUR and a min estimate of 41.98 EUR. Check if this forecast comes true in a year, meanwhile watch CEREVEL THERAP.HLDGS stock price chart and keep track of the current situation with 673 news and stock market news.
We've gathered opinions of 6 analysts rating 673 stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.